Celebrating a successful 2022 ACTA ASM including the Australian Registry ASM


We are thrilled to finish the 2022 ACTA ASM with another successful year. We are also delighted to welcome the Australian Registry ASM for the first time. It was great to see over 300 delegates in-person on 7-8 November at Adelaide’s SAHMRI.

Across the two days, delegates enjoyed various clinical research and registry development discussions from the sector’s most innovative and influential minds. We were pleased to see many people engage in panel discussions and the Registry ASM plenary sessions and interact with our keynote presenters.

The 2022 event themes were: The Value of Registries in Challenging Times at the Australian Registry ASM and Implementing Evidence into Practice: how do we plan, engage and act to ensure our trials have the greatest impact and change practice at the ACTA ASM.

Access to all meeting content including recordings of all live sessions and posters will be available online shortly.

We sincerely thank our Convenors, Prof Susannah Ahern, Prof Stephen McDonald, Prof Rachelle Buchbinder, Prof Andrew Davidson, the Organising Committee, all presenters, and delegates.

ACTA would like to make a special mention to all the presenters delivering engaging talks within their specialty areas. The quality of the content was world-class.

­We would also like to thank our sponsors for their continued support. Without you, these ASMs would not have been possible.

These events have become highlights on the clinical research calendar. We are pleased to confirm our plan to host a live multiple-day event in 2023. Stay tuned for further details. 

The ACTA ASM and the Australian Registry ASM was proudly supported by:

  • Bellberry Limited
  • MTP Connect
  • AstraZeneca
  • Australian Government, Department of Health and Aged Care
  • Spiral Software
  • ARCS Australia
  • Praxis